Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Follow-up Study to Evaluate the Long-term Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV (580299) Vaccine in Healthy Female Subjects

NCT00947115 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00947115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00947115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Follow-up Study to Evaluate the Long-term Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV (580299) Vaccine in Healthy Female Subjects
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
September 22, 2009
Completion date
February 3, 2015
Enrollment
525 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

infections, papillomavirus